Publications 2026

Bischof K, Fredriksen KM, Bjørnstad M, Elstrand MB, Eyjolfsdottir B, Birgisdottir A, Lillo E, Aune G, Lindemann K (2026)
Oncological outcome and immune-checkpoint-blockade-induced toxicities in patients with cervical cancer - a Norwegian real-world cohort
Acta Oncol, 65, 518-524
DOI 10.2340/1651-226X.2026.45737, PubMed 42220011

Publications 2024

Birgisdóttir A, Myklebust TÅ, Bjørnslett M, Rognlien VW, Paulsen T, Dørum A (2024)
BRCA mutation testing and association with oncologic outcome and incidence of ovarian cancer in Norway
Int J Gynecol Cancer, 35 (2), 100029
DOI 10.1016/j.ijgc.2024.100029, PubMed 39971428

Publications 2007

Janson C, Asbjornsdottir H, Birgisdottir A, Sigurjonsdottir RB, Gunnbjörnsdottir M, Gislason D, Olafsson I, Cook E, Jögi R, Gislason T, Thjodleifsson B (2007)
The effect of infectious burden on the prevalence of atopy and respiratory allergies in Iceland, Estonia, and Sweden
J Allergy Clin Immunol, 120 (3), 673-9
DOI 10.1016/j.jaci.2007.05.003, PubMed 17586034

Publications 2006

Birgisdóttir A, Asbjörnsdottir H, Cook E, Gislason D, Jansson C, Olafsson I, Gislason T, Jogi R, Thjodleifsson B (2006)
Seroprevalence of Toxoplasma gondii in Sweden, Estonia and Iceland
Scand J Infect Dis, 38 (8), 625-31
DOI 10.1080/00365540600606556, PubMed 16857606

Publications 2004

Richter MY, Jakobsen H, Birgisdottir A, Haeuw JF, Power UF, Del Giudice G, Bartoloni A, Jonsdottir I (2004)
Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria
Infect Immun, 72 (1), 187-95
DOI 10.1128/IAI.72.1.187-195.2004, PubMed 14688096